The client had developed a novel therapy for the management of diabetes and launched this in the US market​

The client had relatively little experience of the complex pricing and reimbursement process associated with launching in Europe

The client needed an understanding of the potential pricing and uptake for their product in key EU markets, and what it would take to be successful in both the private and public payer markets​

Profile major EU country healthcare systems from both a public and private perspective

Understand the relative size of both the private and public market for the product in each country healthcare system

Develop an understanding of the relevant clinical and access pathways for diabetes products in each country healthcare system​

Understand the dynamics of the competitive environment both now and in the future

Draw together a recommended approach for market launch considerations in Europe

Lightning Health developed a comprehensive desk research protocol to understand the likely positioning of the new asset in diabetes therapy and potential size of the public and private markets across key EU countries ​

A European landscaping book was developed to provide a detailed assessment of the clinical and commercial landscape for the product in each selected market, including an evaluation of the feasibility of access and uptake in the public and private sectors and recommendations for developing the European pricing and launch strategy